Who
Sergei Gryaznov
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, MAIA Biotechnology.
In numbers
- Trades disclosed
- 18
- Buys
- 2
- Sells
- 0
- Bought
- $20K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Aug 2022
- Last trade
- 1 Jun 2026
- Last filed
- 2 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 2 Jun 2026 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $2,6902,000 at $1.35 | filing |
| 1 Jun 2026filed 2 Jun 2026 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $2,7002,000 at $1.35 | filing |
| 29 May 2026filed 1 Jun 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 29 May 2026filed 1 Jun 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 26 Apr 2024filed 30 Apr 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —141,000 at $0.00 | filing |
| 24 Jan 2024filed 26 Jan 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 31 May 2023filed 5 Jun 2023 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,982 at $0.00 | filing |
| 8 Mar 2023filed 10 Mar 2023 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 7 Dec 2022filed 8 Dec 2022 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 7 Dec 2022filed 8 Dec 2022 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Code M | $18K10,000 at $1.83 | filing |
| 16 Sep 2022filed 20 Sep 2022 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 24 Aug 2022filed 25 Aug 2022 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 24 Aug 2022filed 25 Aug 2022 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Code M | $18K10,000 at $1.80 | filing |
| 1 Aug 2022filed 2 Aug 2022 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $15K3,000 at $5.00 | filing |
News
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 0.8% – Here's What HappenedMAIA · dailypolitical.com · 8 Oct 2026MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung CancerMAIA · manilatimes.net · 7 Oct 2026
0 headlines in the last 90 days name Sergei Gryaznov; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.